Subscribe Login
DE4CC0DE-5FC3-4494-BCBF-4D50B00366B5
Retail

Orkla Divests Skin Care Business In Poland

By Dayeeta Das
Share this article

Orkla Care Poland has entered into an agreement to sell the company’s skin care business in Poland to Bielenda Kosmetyki Naturalne Sp. z o. o. Spółka Komandytowa.

Orkla has described the decision as a means of streamlining its portfolio and concentrating all Polish operations on health, wound care, cleaning products, and personal care product categories.

The deal between Orkla and Bielenda covers the Soraya and Dermika brands, 145 employees, and production facilities in Radzymin.

CEO of Orkla Care, Atle Vidar Nagel Johansen said that the sale to Bielenda "will contribute to a more focused and robust Orkla Care Poland".

Bielenda is a family-owned manufacturer and supplier of branded beauty and skin care products. Established in 1990, it is now one of the leading suppliers of branded skin care products in the Polish market.

The agreement, which is subject to the approval of the Polish competition authorities, is expected to take effect at the beginning of  year. Both parties have agreed not to disclose the price.

© 2021 European Supermarket Magazine – your source for the latest retail news. Article by Conor Farrelly. Click subscribe to sign up to ESM: The European Supermarket Magazine.

Stay Connected With Our Weekly Newsletter

Processing your request...

Thanks! please check your email to confirm your subscription.

By signing up you are agreeing to our Terms & Conditions and Privacy Policy
Enjoy unlimited digital access for 30 days
Get exclusive access to the latest grocery retail & FMCG news, interviews with industry leading executives, and expert analysis on the trends shaping the sector today
Enjoy unlimited digital access for 30 days
Enjoy unlimited digital access for 30 days
Get exclusive access to the latest grocery retail & FMCG news, interviews with industry leading executives, and expert analysis on the trends shaping the sector today
Enjoy unlimited digital access for 30 days

Copyright © 2023. All rights reserved. Developed by Square1 and powered by PublisherPlus.com